当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 现金流量表

恩华药业

(002262)

  

流通市值:216.82亿  总市值:249.17亿
流通股本:8.84亿   总股本:10.16亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,856,768,608.143,139,587,953.991,518,036,956.15,938,902,382.23
  收到的税费返还382,653.19370,401.75346,253.96253,387.85
  收到其他与经营活动有关的现金71,416,256.2640,530,139.7733,032,293.9975,608,438.63
  经营活动现金流入小计4,928,567,517.593,180,488,495.511,551,415,504.056,014,764,208.71
  购买商品、接受劳务支付的现金1,138,791,461.72832,410,420.4365,131,720.521,290,808,305.73
  支付给职工以及为职工支付的现金819,115,801.87477,274,732.84236,337,206.26994,451,862.99
  支付的各项税费560,502,997.54383,546,004176,092,116.43738,389,529.24
  支付其他与经营活动有关的现金1,499,010,699.51992,434,138.95454,582,161.372,074,988,007.69
  经营活动现金流出小计4,017,420,960.642,685,665,296.191,232,143,204.585,098,637,705.65
  经营活动产生的现金流量净额911,146,556.95494,823,199.32319,272,299.47916,126,503.06
二、投资活动产生的现金流量:
  取得投资收益收到的现金38,124,521.1828,616,017.3618,089,170.3246,119,276.83
  处置固定资产、无形资产和其他长期资产收回的现金净额146,482.462,948.418,000799,445.43
  收到的其他与投资活动有关的现金5,822,000,0004,388,000,0002,277,000,0006,201,010,000
  投资活动现金流入小计5,860,271,003.584,416,678,965.762,295,107,170.326,247,928,722.26
  购建固定资产、无形资产和其他长期资产支付的现金232,632,606.43151,681,742.5372,876,622.99450,055,947.44
  投资支付的现金25,158,70025,158,70040,000-
  取得子公司及其他营业单位支付的现金43,00043,000-340,400
  支付其他与投资活动有关的现金5,632,000,0003,940,000,0001,816,000,0007,209,010,000
  投资活动现金流出小计5,889,834,306.434,116,883,442.531,888,916,622.997,659,406,347.44
  投资活动产生的现金流量净额-29,563,302.85299,795,523.23406,190,547.33-1,411,477,625.18
三、筹资活动产生的现金流量:
  吸收投资收到的现金---98,855,937
  取得借款收到的现金40,000,00040,000,000-65,000,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计40,000,00040,000,000-163,855,937
  偿还债务支付的现金55,000,00015,000,0005,000,000105,000,000
  分配股利、利润或偿付利息支付的现金367,016,667.36366,805,667.35536,694.45323,774,577.78
  支付其他与筹资活动有关的现金28,060,993.6815,627,976.736,861,551.5236,051,872.07
  筹资活动现金流出小计450,077,661.04397,433,644.0812,398,245.97464,826,449.85
  筹资活动产生的现金流量净额-410,077,661.04-357,433,644.08-12,398,245.97-300,970,512.85
四、汇率变动对现金及现金等价物的影响222,198.59524,324.56-136,359.25171,089.65
五、现金及现金等价物净增加额471,727,791.65437,709,403.03712,928,241.58-796,150,545.32
  加:期初现金及现金等价物余额1,213,462,279.971,213,462,279.971,213,462,279.972,009,612,825.29
  期末现金及现金等价物余额1,685,190,071.621,651,171,6831,926,390,521.551,213,462,279.97
补充资料:
  净利润-700,054,285.99-1,140,792,302.84
  资产减值准备-22,034,891.47-73,644,009.77
  固定资产和投资性房地产折旧-71,819,044.68-132,277,340.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,819,044.68-132,277,340.56
  无形资产摊销-11,202,953.49-19,157,803.46
  长期待摊费用摊销-35,058,245.07-52,187,688.57
  处置固定资产、无形资产和其他长期资产的损失--41,856.14--293,968.27
  固定资产报废损失-290,590.89--68,993.34
  财务费用-720,798.92-3,854,788.55
  投资损失--32,479,568.44--65,568,560.11
  递延所得税--12,105,683.84-1,585,817.52
  其中:递延所得税资产减少--11,994,663.43-2,935,866.1
    递延所得税负债增加--111,020.41--1,350,048.58
  存货的减少--88,128,921.13--71,797,464.89
  经营性应收项目的减少--333,723,230.86--512,980,906.9
  经营性应付项目的增加-67,665,567.69-81,709,654.68
  其他-37,274,958-31,051,725.7
  现金的期末余额-1,651,171,683-1,213,462,279.97
  减:现金的期初余额-1,213,462,279.97-2,009,612,825.29
  现金及现金等价物的净增加额-437,709,403.03--796,150,545.32
公告日期2025-10-252025-07-302025-04-192025-03-29
审计意见(境内)标准无保留意见
TOP↑